Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
4D-310 by 4D Molecular Therapeutics for Fabry Disease: Likelihood of Approval
4D-310 is under clinical development by 4D Molecular Therapeutics and currently in Phase II for Fabry Disease. According to GlobalData,...